Literature DB >> 23122408

Folding and dimerization kinetics of bone morphogenetic protein-2, a member of the transforming growth factor-β family.

Luis F Vallejo1, Ursula Rinas.   

Abstract

The kinetics of folding and dimerization of bone morphogenetic protein-2 (BMP-2), a disulfide-connected, homodimeric cystine-knot protein and a member of the transforming growth factor-β superfamily, was analyzed under a variety of different conditions. Refolding and dimerization of BMP-2 were extremely slow under all conditions studied, and could be described by consecutive first-order reactions involving at least one long-lived intermediate. The rate constants vary from ~ 0.2 × 10(-5) to ~ 3.5 × 10(-5) s(-1), and were strongly dependent on temperature, redox conditions, and the presence of stabilizing or destabilizing ions. In particular, the combined impact of ionic strength and redox conditions on the rates indicates that electrostatic interactions control thiol-disulfide exchange reactions on the path from the unfolded and reduced monomers to the disulfide-connected growth factor in a rate-determining way.
© 2012 The Authors Journal compilation © 2012 FEBS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23122408     DOI: 10.1111/febs.12051

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  9 in total

1.  Stability and Biological Activity of E. coli Derived Soluble and Precipitated Bone Morphogenetic Protein-2.

Authors:  Bastian Quaas; Laura Burmeister; Zhaopeng Li; Alexandra Satalov; Peter Behrens; Andrea Hoffmann; Ursula Rinas
Journal:  Pharm Res       Date:  2019-11-20       Impact factor: 4.200

2.  Structural Mapping of BMP Conformational Epitopes and Bioengineering Design of Osteogenic Peptides to Specifically Target the Epitope-Binding Sites.

Authors:  Hao Chen; Yaodong Zhou; Qirong Dong
Journal:  Cell Mol Bioeng       Date:  2022-04-28       Impact factor: 3.337

3.  Grafting, Stripping and Stapling of Helical Peptides from the Dimerization Interface of ONFH-Related Bone Morphogenetic Protein-2.

Authors:  Wenqi Song; Kunzheng Wang; Wei Wang; Pei Yang; Xiaoqian Dang
Journal:  Protein J       Date:  2019-02       Impact factor: 2.371

4.  Rational design of type-IA receptor-derived cyclic peptides to target human bone morphogenic protein 2.

Authors:  Xiaohua Fan; Hai Xia; Xiaoyun Liu; Benying Li; Jun Fang
Journal:  J Biosci       Date:  2019-12       Impact factor: 1.826

5.  Characterization of human bone morphogenetic protein gene variants for possible roles in congenital heart disease.

Authors:  Fei-Feng Li; Xia Deng; Jing Zhou; Peng Yan; Er-Ying Zhao; Shu-Lin Liu
Journal:  Mol Med Rep       Date:  2016-06-23       Impact factor: 2.952

6.  Incorporation of heparin-binding proteins into preformed dextran sulfate-chitosan nanoparticles.

Authors:  Paula Zaman; Julia Wang; Adam Blau; Weiping Wang; Tina Li; Daniel S Kohane; Joseph Loscalzo; Ying-Yi Zhang
Journal:  Int J Nanomedicine       Date:  2016-11-18

7.  Inclusion Body Expression and Refolding of Recombinant Bone Morphogenetic Protein-2.

Authors:  Davood Nasrabadi; Siamak Rezaeiani; Ali Sayadmanesh; Mohamadreza Baghaban Eslaminejad; Aliakbar Shabani
Journal:  Avicenna J Med Biotechnol       Date:  2018 Oct-Dec

8.  Structural determinants and genetic modifications enhance BMP2 stability and extracellular secretion.

Authors:  Vinayak Khattar; Joo Hyoung Lee; Hong Wang; Soniya Bastola; Selvarangan Ponnazhagan
Journal:  FASEB Bioadv       Date:  2018-11-14

9.  MB109 as bioactive human bone morphogenetic protein-9 refolded and purified from E. coli inclusion bodies.

Authors:  Mario Meng-Chiang Kuo; Phuong Hong Nguyen; Yun-Hui Jeon; Subin Kim; So-Mi Yoon; Senyon Choe
Journal:  Microb Cell Fact       Date:  2014-02-24       Impact factor: 5.328

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.